BioSpace News Archive

Press Releases

Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet’s Disease

February 26, 2026

·

12 min read

Press Releases

Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris

February 26, 2026

·

4 min read

Press Releases

ImmunityBio Completes Enrollment in Pivotal Randomized Trial Evaluating ANKTIVA® Plus BCG Versus BCG Alone in BCG-Naïve Non-Muscle Invasive Bladder Cancer Carcinoma In Situ

February 26, 2026

·

8 min read

Two arrow signs representing the new way and old way approach to business

Regulatory

Atara Climbs Amid Report of FDA Inconsistency Leading to Cell Therapy’s Rejection

The rejection of Atara Biotherapeutics’ Ebvallo in January was a “complete reversal” of the conesensus FDA reviewers had come to, according to a former agency employee, who said manufacturing problems were the only approvability barrier for the drug.

February 26, 2026

·

1 min read

·

Tristan Manalac

Close up shot of the dart arrow hit on bulleyes of dartboard to represent that the business reached the target with dark tone picture style. Target and goal as concept.

Diabetes

Lilly Tops Novo in Weight Loss Again, This Time on the Oral Front

Novo Nordisk reported a loss in a head-to-head trial of CagriSema against Lilly’s Zepbound earlier this week. This time around, Lilly’s orforglipron bested Novo’s oral semaglutide in blood sugar control and weight reduction—albeit with a few extra discontinuations as compared to its rival.

February 26, 2026

·

2 min read

·

Annalee Armstrong

Press Releases

SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247

February 26, 2026

·

3 min read

Press Releases

Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product